The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Functional Selectivity through Protean and Biased Agonism: Who Steers the Ship?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transduction of Receptor Signals by ß-Arrestins
Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727
Molecular tinkering of G protein-coupled receptors: an evolutionary success
Bockaert, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1723 · Cited by 1,550
Differential signal transduction by five splice variants of the PACAP receptor
Spongier, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburgt, P. H., & Journot, L. (1993) · Nature · doi:10.1038/365170a0 · Cited by 1,182
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Operational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 951
Pharmacologic Analysis of Drug Receptor Interaction
Kenakin, K. T. (1988) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198803000-00029 · Cited by 927
Agonist-receptor efficacy II: agonist trafficking of receptor signals
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89032-x · Cited by 657
Self-citationKjelsberg, M. A., Cotecchia, S., Ostrowski, J., Caron, M. G., & Lefkowitz, R. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45962-5 · Cited by 589
Azzi, M., Charest, P. G., Angers, S., Rousseau, G., Kohout, T., Bouvier, M., & Piñeyro, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1936664100 · Cited by 523
Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., & Clarke, W. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.94 · Cited by 510
Historical review: A brief history and personal retrospective of seven-transmembrane receptors
Lefkowitz, R. J. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.006 · Cited by 417
Lawler, C. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00099-2 · Cited by 408
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
KENAKIN, T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0438rev · Cited by 408
Self-citationGhanouni, P., Gryczynski, Z., Steenhuis, J. J., Lee, T. W., Farrens, D. L., Lakowicz, J. R., & Kobilka, B. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100162200 · Cited by 364
Coupling ligand structure to specific conformational switches in the β2-adrenoceptor
Yao, X., Parnot, C., Deupi, X., Ratnala, V. R. P., Swaminath, G., Farrens, D., & Kobilka, B. (2006) · Nature Chemical Biology · doi:10.1038/nchembio801 · Cited by 353
Sequential Binding of Agonists to the β2 Adrenoceptor
Swaminath, G., Xiang, Y., Lee, T. W., Steenhuis, J., Parnot, C., & Kobilka, B. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310888200 · Cited by 333
Eason, M. G., Kurose, H., Holt, B. D., Raymond, J. R., & Liggett, S. B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49605-1 · Cited by 330
Ligand-selective receptor conformations revisited: the promise and the problem
Kenakin, T. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00167-6 · Cited by 321
Self-citationLaugwitz, K. L., Allgeier, A., Offermanns, S., Spicher, K., Van Sande, J., Dumont, J. E., & Schultz, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.116 · Cited by 317
Drug Efficacy at G Protein–Coupled Receptors
Kenakin, T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091401.113012 · Cited by 316
Self-citationNew Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors
Lefkowitz, R. J., Rajagopal, K., & Whalen, E. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.007 · Cited by 301
Galandrin, S., & Bouvier, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026716 · Cited by 291
Fluorescent Labeling of Purified β2 Adrenergic Receptor
Gether, U., Lin, S., & Kobilka, B. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28268 · Cited by 278
The classification of seven transmembrane receptors in recombinant expression systems.
Kenakin, T. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06948-0 · Cited by 270
Self-citationEfficacy at g-protein-coupled receptors
Kenakin, T. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd722 · Cited by 263
Self-citationBrady, A. E., & Limbird, L. E. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00239-x · Cited by 263
Multiple Signaling States of G-Protein-Coupled Receptors
Perez, D. M., & Karnik, S. S. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.2 · Cited by 237
Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism
Kenakin, T. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.2 · Cited by 213
Self-citationKenakin, T. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.009 · Cited by 213
Self-citationBaker, J. G., Hall, I. P., & Hill, S. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1357 · Cited by 189
Oppermann, M., Mack, M., Proudfoot, A. E. I., & Olbrich, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8875 · Cited by 185
Charest, P. G., Terrillon, S., & Bouvier, M. (2005) · EMBO reports · doi:10.1038/sj.embor.7400373 · Cited by 172
Activation-dependent Conformational Changes in β-Arrestin 2
Xiao, K., Shenoy, S. K., Nobles, K., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409785200 · Cited by 158
Amino-terminally Modified RANTES Analogues Demonstrate Differential Effects on RANTES Receptors
Proudfoot, A. E. I., Buser, R., Borlat, F., Alouani, S., Soler, D. F., Offord, R. E., Schröder, J.-M., Power, C., & Wells, T. N. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32478 · Cited by 153
Chemically Distinct Ligands Promote Differential CB1 Cannabinoid Receptor-Gi Protein Interactions
Mukhopadhyay, S., & Howlett, A. C. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.003558 · Cited by 148
Palanché, T., Ilien, B., Zoffmann, S., Reck, M.-P., Bucher, B., Edelstein, S. J., & Galzi, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104363200 · Cited by 132
Identification of Allosteric Peptide Agonists of CXCR4
Sachpatzidis, A., Benton, B. K., Manfredi, J. P., Wang, H., Hamilton, A. D., Dohlman, H. G., & Lolis, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204667200 · Cited by 117
Receptor activity‐independent recruitment of βarrestin2 reveals specific signalling modes
Terrillon, S., & Bouvier, M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600387 · Cited by 115
Luttrell, L. M. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:26:2-3:253 · Cited by 113
Watson, C., Chen, G., Irving, P. E., Way, J. M., Chen, W.-J., & Kenakin, T. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1230 · Cited by 103
Self-citationMathiesen, J. M., Ulven, T., Martini, L., Gerlach, L. O., Heinemann, Á., & Kostenis, E. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010520 · Cited by 100
Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
Chidiac, P., Nouet, S., & Bouvier, M. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09338-1 · Cited by 93
Münch, G. W., Dees, C., Hekman, M., & Palm, D. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16023.x · Cited by 92
Gavarini, S., Bécamel, C., Altier, C., Lory, P., Poncet, J., Wijnholds, J., Bockaert, J., & Marin, P. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-03-0218 · Cited by 75
Ikezu, T., Okamoto, T., Ogata, E., & Nishimoto, I. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81359-t · Cited by 69
Collateral efficacy as a pharmacological problem applied to new drug discovery
Kenakin, T. (2006) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.1.7.635 · Cited by 25
Self-citation
Cited by
Cannabinoid Receptors: Where They are and What They do
Mackie, K. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01671.x · Cited by 638
Kenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573
Self-citationQuantifying Ligand Bias at Seven-Transmembrane Receptors
Rajagopal, S., Ahn, S., Rominger, D. H., Gowen-MacDonald, W., Lam, C. M., DeWire, S. M., Violin, J. D., & Lefkowitz, R. J. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.072801 · Cited by 388
Violin, J. D., DeWire, S. M., Yamashita, D., Rominger, D. H., Nguyen, L., Schiller, K., Whalen, E. J., Gowen, M., & Lark, M. W. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173005 · Cited by 370
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Luttrell, L. M., Gesty-Palmer, D., & Sibley, D. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002436 · Cited by 369
Metadata
- Authors
- Kenakin, T.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2007-12
- Volume
- 72
- Issue
- 6
- Pages
- 1393-1401
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2096227949
- Cited by
- 270
- References
- 46
- FWCI
- 12.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.